Your browser doesn't support javascript.
loading
Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma.
Li, Gaowei; Zhang, Zongliang; Cai, Linjun; Tang, Xin; Huang, Jianhan; Yu, Lingyu; Wang, Guoqing; Zhong, Kunhong; Cao, Yi; Liu, Chang; Wang, Yuelong; Tong, Aiping; Zhou, Liangxue.
Afiliação
  • Li G; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Zhang Z; State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Cai L; Department of Neurology, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Tang X; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Huang J; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Yu L; Department of Otolaryngology, Head and Neck Surgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Wang G; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Zhong K; State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Cao Y; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Liu C; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Wang Y; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Tong A; State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
  • Zhou L; Department of Neurosurgery, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
Oncoimmunology ; 10(1): 1983306, 2021.
Article em En | MEDLINE | ID: mdl-34595061

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article